Xtant Medical Expects FY2024 Sales Of $112M-$116M Versus Consensus Of $115.95M
Portfolio Pulse from Benzinga Newsdesk
Xtant Medical forecasts its FY2024 sales to be in the range of $112M-$116M, closely aligning with the consensus estimate of $115.95M.

April 01, 2024 | 11:14 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Xtant Medical's FY2024 sales forecast aligns closely with market expectations, indicating stable financial performance.
The forecasted sales range of $112M-$116M by Xtant Medical for FY2024 is very close to the consensus estimate of $115.95M, suggesting that the company's financial performance is in line with market expectations. This alignment typically indicates a neutral impact on the stock price in the short term, as there are no significant positive or negative surprises.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100